International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 385-391 , May 2005

Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori

  • M.C. Collado

      Affiliations

    • Dept. Ciencia de Alimentos, Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Apartado de correos 73, 46100 Burjassot, Valencia, Spain
    • Dept. Biotecnología, Área de Microbiología, Universidad Politécnica de Valencia, Camino de Vera 14, 46022 Valencia, Spain
    • ,
  • A. González

      Affiliations

    • Dept. Biotecnología, Área de Microbiología, Universidad Politécnica de Valencia, Camino de Vera 14, 46022 Valencia, Spain
    • ,
  • R. González

      Affiliations

    • Servicio de Microbiología, Hospital Universitario Dr. Peset, Avenida Gaspar Aguilar 90, 46017 Valencia, Spain
    • ,
  • M. Hernández

      Affiliations

    • Dept. Biotecnología, Área de Microbiología, Universidad Politécnica de Valencia, Camino de Vera 14, 46022 Valencia, Spain
    • ,
  • M.A. Ferrús

      Affiliations

    • Dept. Biotecnología, Área de Microbiología, Universidad Politécnica de Valencia, Camino de Vera 14, 46022 Valencia, Spain
    • ,
  • Y. Sanz

      Affiliations

    • Dept. Ciencia de Alimentos, Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Apartado de correos 73, 46100 Burjassot, Valencia, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 96 3900022; fax: +34 96 3636301.

Received 9 August 2004 ,Accepted 12 January 2005.

References 

  1. Go MF. Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharm Ther. 2002;16:1–15
  2. Blaser MJ, Atherton C. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321–333
  3. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997;113:1983–1991
  4. Hamilton-Miller JMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents. 2003;22:360–366
  5. Matsumoto S, Washizuka Y, Matsumoto Y, et al. Appearance of metronidazole-resistant Helicobacter pylori strain in an Infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains. Antimicrob Agents Chemother. 1997;41:2602–2605
  6. Graham DY. Community acquired acute Helicobacter pylori gastritis. J Gastroenterol Hepatol. 2000;15:1353–1355
  7. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek. 2002;82:279–289
  8. Bernet MF, Brassart D, Neeser JR, et al. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell-attachment and cell-invasion by enterovirulent bacteria. Gut. 1994;35:483–489
  9. Sgouras D, Maragkoudakis P, Petraki K, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol. 2004;70:518–526
  10. Yildirim Z, Johnson MG. Characterization and antimicrobial spectrum of Bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J Food Prot. 1998;61:47–51
  11. Gasson MJ. Plasmid complements of Streptococcus lactis NCDO712 and other lactic streptococci after protoplast induced curing. J Bacteriol. 1983;154:1–9
  12. Nebra Y, Blanch AR. A new selective medium for Bifidobacterium spp. Appl Environ Microbiol. 1999;65:5173–5176
  13. Wilson K. Preparation of genomic DNA from bacteria. In:  Ausubel FM,  Brent R,  Kingston RE, et al. editor. Current protocols in molecular biology. New York: John Wiley & Sons; 1987;
  14. Burucoa C, Lhomme V, Fauchere JL. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J Clin Microbiol. 1999;37:4071–4080
  15. Kaufmann P, Pfefferkorn A, Teuber M, et al. Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16S rRNA-targeted probes by colony hybridisation and PCR. Appl Environ Microbiol. 1997;63:1268–1273
  16. Tynkkynen S, Satokari R, Sarela M, et al. Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and Lactobacillus casei strains. Appl Environ Microbiol. 1999;65:3908–3914
  17. Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother. 1999;43:2747–2752
  18. Felley C, Michetti P. Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol. 2003;17:785–791
  19. Aiba Y, Suzuki N, Kabir AM, et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol. 1998;93:2097–2101
  20. Sakamoto I, Igarashi M, Kimura K, et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother. 2001;47:709–710
  21. Kim TS, Hur JW, Yu MA, et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot. 2003;66:3–12
  22. Charteriss WP, Kelly PM, Morelli L, et al. Effect of conjugated bile salts on antibiotic susceptibility of bile salt-tolerant Lactobacillus and Bifidobacterium isolates. J Food Prot. 2000;63:1369–1376
  23. Falsafis T, Mobasheri F, Nariman F, et al. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol. 2004;42:387–389

PII: S0924-8579(05)00031-2

doi: 10.1016/j.ijantimicag.2005.01.017

International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 385-391 , May 2005

Article Tools

* Image Usage & Resolution